Novo Nordisk and Vivtex are to co-develop next-generation oral biologic therapies to treat obesity, diabetes and related ...

Our viewpoint is that in cases of ultra rare diseases where there is no commercial model or opportunity for traditional forms of investment, access to gene therapies could be provided via a clinical ...

IQVIA Holdings has signed an agreement to acquire selected discovery service assets from Charles River Laboratories, aiming to expand its end-to-end capabilities.

The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.

Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.

AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...

Slate Medicines has secured a $130m Series A financing round aimed at advancing anti-PACAP migraine therapies.

NorthX Biologics and Demeetra have entered a strategic partnership focused on integrated CLD and GMP manufacturing.

The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the ...

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) to enhance pharmaceutical education and research ...

J&J's Pennsylvania cell therapy manufacturing site is one of four US-based facilities the company plans to build over the ...